sars-cov-2 antigen rapid test
uses nasal swab specimens from individuals suspected of active covid-19 by their doctor within the first seven days of the onset of symptoms.
uses nasal swab specimens from individuals suspected of active covid-19 by their doctor within the first seven days of the onset of symptoms.
use a simple, rapid protocol to generate high-quality templates for a broad range of downstream applications
• fast procedures and easy to use.
• isolation and purification of high-quality viral dna/rna.
• high efficient recovery yield.
• pure dna/rna ready for downstream applications.
• no phenol-chloroform extraction.feature | specifications |
format | spin column |
technology | silica-membrane technology |
sample volume | 200 μl |
elution volume | 50 μl |
sample type | serum, plasma, swab |
yield | > 90% recovery |
processing | manual (centrifugation) |
processing time per run | 15 - 30min |
purication of total rna, mirna, poly a mrna, dna or protein | viral dna or viral rna |